TinySeed, the next generation of startup accelerators founded by serial entrepreneurs Rob Walling and Einar Vollset, is thrilled to announce that we have successfully raised $100,000 to further empower early-stage, non-unicorn startups. Our journey began back in late 2018 when we observed a glaring gap in the startup funding ecosystem—a need for an alternative model that supports promising SaaS companies without forcing them to chase unrealistic billion-dollar valuations. The overwhelming response on social media and platforms like Hacker News confirmed the pent-up demand for our unique approach to startup acceleration. This funding will be strategically deployed to expand our remote, year-long accelerator program, refining our tailored coaching, mentorship, and resource network for startups seeking sustainable growth. By embracing a framework that celebrates businesses doing $10 million in annual revenue rather than fixating on unicorn status, we intend to back companies that create solid, profitable ventures among a vast and underserved market segment. With this new injection of capital, we will enhance our digital infrastructure, invest in additional expert mentors, and extend our community outreach to attract a wider pool of innovative founders. Our commitment to transforming the entrepreneurial landscape remains steadfast, and this investment is a powerful endorsement of our mission to revolutionize early-stage startup funding. As we continue to build on our success, TinySeed is excited to support a new wave of entrepreneurs committed to forging their own path to profitability and long-term stability.

TinySeed Raises $100K: Pioneering a New Era for Non-Unicorn SaaS Startups
Get the full TinySeed company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
BioStem Technologies
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
$2.5M Unknown
today

Edify Systems
When you're running 10+ stores, the cracks in your operations become expensive. Inconsistent stock levels across sites, manual processes that don't scale, food waste that eats into margins, and zero real time visibility for the ops team. That's what Edify solves. Our AI powered platform gives operations leaders a single system to manage inventory, plan production, and report across their entire estate, whether that's 20 locations or 500. Built in intelligence surfaces the insights that matter, so your team spends less time in spreadsheets and more time running operations. What we cover: Inventory management across all sites. AI driven production planning and prep workflows. Operational reporting and real time visibility. Multi location scalability built in from day one. We work with QSR brands and multi site coffee chains who have outgrown spreadsheets and fragmented systems but need something purpose built for high volume, multi unit operations. If your back of house is holding back your growth, we should talk.
$4.0M Seed
today

Generalist
Generalist is an AI robotics company building general intelligence for the physical world. The founding team includes engineers from OpenAI, Google DeepMind, and Boston Dynamics. The company embraces both large-scale AI and robotics as core to its DNA.
$400.0M Unknown
today

Scotch
From neighborhood stores to destination warehouses, liquor retailers of all sizes have been held back by manual tasks, slow systems and limited business intelligence. So we decided to build something better — smarter software that saves time and improves margins so independent retailers could focus on their customers, not manually managing inventory.
$20.0M Series a
today

Kempfer / K Creative Office
Based in São Paulo, we specialize in social media creation and content, delivering creative solutions that connect, engage, and inspire Com sede em São Paulo, somos especialistas em criação e conteúdo para social media, entregando soluções criativas que conectam, envolvem e inspiram.
$1.3M Unknown
today